Kelly Pimenta

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 3

Top Topics

Minimally Invasive

Tyrosine Kinase

Epidermal Growth Factor Receptor

Top Venues

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Matthew P Smeltzer, Olawale A Akinbobola, Meredith A Ray, Carrie Fehnel, Andrea Saulsberry, Kourtney R Dortch, Kelly Pimenta, Anberitha T Matthews, Raymond U Osarogiagbon
Prevalence of Epidermal Growth Factor Receptor and Programmed Death Ligand 1 Testing in a Population-Based Lung Cancer Surgical Resection Cohort from 2018 to 2022. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 33 (8) (2024)
Matthew P Smeltzer, Olawale A Akinbobola, Meredith A Ray, Carrie Fehnel, Andrea Saulsberry, Kourtney R Dortch, Kelly Pimenta, Anberitha T Matthews, Raymond U Osarogiagbon
Prevalence of Epidermal Growth Factor Receptor and Programmed Death-Ligand 1 testing in a population-based lung cancer surgical resection cohort from 2018-2022. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (2024)
Matthew P Smeltzer, Olawale A Akinbobola, Meredith A Ray, Carrie Fehnel, Andrea Saulsberry, Kourtney R Dortch, Kelly Pimenta, Anberitha T Matthews, Raymond U Osarogiagbon
Prevalence of Epidermal Growth Factor Receptor and Programmed Death Ligand 1 Testing in a Population-Based Lung Cancer Surgical Resection Cohort from 2018 to 2022. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 33 (8) (2024)